カテゴリー： Market Monitor Global, 世界, 医療/バイオ

経皮・皮内薬物送達用マイクロニードルの世界市場見通し2023年-2029年

◆英語タイトル：Microneedles for Trans & Intradermal Drug Delivery Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5288）

◆商品コード：MMG23JU5288
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Microneedles for Trans & Intradermal Drug Delivery Market 調査レポートは次の情報を含め、グローバルにおけるの経皮・皮内薬物送達用マイクロニードル市場規模と予測を収録しています。・世界の経皮・皮内薬物送達用マイクロニードル市場：売上、2018年-2023年、2024年-2029年
・世界の経皮・皮内薬物送達用マイクロニードル市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経皮・皮内薬物送達用マイクロニードル市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「中実マイクロニードル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

経皮・皮内薬物送達用マイクロニードルのグローバル主要企業は、Becton Dickinson、 Nanopass Technologies、 Radius Health、 Clearside Biomedical、 Dr. Prausnitz Group、 Zosano Pharma、 Corium International、 Circassia、 Valeritas, Inc.、 BD Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、経皮・皮内薬物送達用マイクロニードルのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の経皮・皮内薬物送達用マイクロニードル市場：タイプ別、2018年-2023年、2024年-2029年
世界の経皮・皮内薬物送達用マイクロニードル市場：タイプ別市場シェア、2022年
・中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル

世界の経皮・皮内薬物送達用マイクロニードル市場：用途別、2018年-2023年、2024年-2029年
世界の経皮・皮内薬物送達用マイクロニードル市場：用途別市場シェア、2022年
・医薬品、ワクチン、プロテイン、ペプチド、その他

世界の経皮・皮内薬物送達用マイクロニードル市場：地域・国別、2018年-2023年、2024年-2029年
世界の経皮・皮内薬物送達用マイクロニードル市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル売上、2018年-2023年
・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル売上シェア、2022年
・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル販売量、2018年-2023年
・主要企業における経皮・皮内薬物送達用マイクロニードルのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Becton Dickinson、 Nanopass Technologies、 Radius Health、 Clearside Biomedical、 Dr. Prausnitz Group、 Zosano Pharma、 Corium International、 Circassia、 Valeritas, Inc.、 BD Medical

*************************************************************

・調査・分析レポートの概要
経皮・皮内薬物送達用マイクロニードル市場の定義
市場セグメント
世界の経皮・皮内薬物送達用マイクロニードル市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経皮・皮内薬物送達用マイクロニードル市場規模
世界の経皮・皮内薬物送達用マイクロニードル市場規模：2022年 VS 2029年
世界の経皮・皮内薬物送達用マイクロニードル市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経皮・皮内薬物送達用マイクロニードルの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経皮・皮内薬物送達用マイクロニードル製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：中実マイクロニードル、中空マイクロニードル、溶解型マイクロニードル
経皮・皮内薬物送達用マイクロニードルのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医薬品、ワクチン、プロテイン、ペプチド、その他
経皮・皮内薬物送達用マイクロニードルの用途別グローバル売上・予測

・地域別市場分析
地域別経皮・皮内薬物送達用マイクロニードル市場規模 2022年と2029年
地域別経皮・皮内薬物送達用マイクロニードル売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Becton Dickinson、 Nanopass Technologies、 Radius Health、 Clearside Biomedical、 Dr. Prausnitz Group、 Zosano Pharma、 Corium International、 Circassia、 Valeritas, Inc.、 BD Medical
...

This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery. This report contains market size and forecasts of Microneedles for Trans & Intradermal Drug Delivery in global, including the following market information:
Global Microneedles for Trans & Intradermal Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Microneedles for Trans & Intradermal Drug Delivery Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Microneedles for Trans & Intradermal Drug Delivery companies in 2022 (%)
The global Microneedles for Trans & Intradermal Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Solid Microneedles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia and Valeritas, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microneedles for Trans & Intradermal Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microneedles for Trans & Intradermal Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Global Microneedles for Trans & Intradermal Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Drugs
Vaccines
Proteins
Peptides
Others
Global Microneedles for Trans & Intradermal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microneedles for Trans & Intradermal Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Microneedles for Trans & Intradermal Drug Delivery revenues share in global market, 2022 (%)
Key companies Microneedles for Trans & Intradermal Drug Delivery sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Microneedles for Trans & Intradermal Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Microneedles for Trans & Intradermal Drug Delivery, market overview.
Chapter 2: Global Microneedles for Trans & Intradermal Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microneedles for Trans & Intradermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Microneedles for Trans & Intradermal Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Microneedles for Trans & Intradermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microneedles for Trans & Intradermal Drug Delivery Overall Market Size
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size: 2022 VS 2029
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Microneedles for Trans & Intradermal Drug Delivery Players in Global Market
3.2 Top Global Microneedles for Trans & Intradermal Drug Delivery Companies Ranked by Revenue
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Companies
3.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Companies
3.5 Global Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Microneedles for Trans & Intradermal Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Microneedles for Trans & Intradermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Solid Microneedles
4.1.3 Hollow Microneedles
4.1.4 Dissolvable Microneedles
4.2 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
4.2.1 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2023
4.2.2 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2024-2029
4.2.3 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
4.3.1 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2023
4.3.2 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2024-2029
4.3.3 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
4.4 By Type – Global Microneedles for Trans & Intradermal Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Market Size, 2022 & 2029
5.1.2 Drugs
5.1.3 Vaccines
5.1.4 Proteins
5.1.5 Peptides
5.1.6 Others
5.2 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
5.2.1 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2023
5.2.2 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2024-2029
5.2.3 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
5.3.1 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2023
5.3.2 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2024-2029
5.3.3 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
5.4 By Application – Global Microneedles for Trans & Intradermal Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Market Size, 2022 & 2029
6.2 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
6.2.1 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2023
6.2.2 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2024-2029
6.2.3 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
6.3.1 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2023
6.3.2 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2024-2029
6.3.3 By Region – Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.4.2 By Country – North America Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.4.3 US Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.4.4 Canada Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.5.2 By Country – Europe Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.5.3 Germany Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.4 France Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.6 Italy Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.7 Russia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.6.2 By Region – Asia Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.6.3 China Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.4 Japan Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.6.7 India Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.7.2 By Country – South America Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.7.3 Brazil Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, 2018-2029
6.8.3 Turkey Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8.4 Israel Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
6.8.6 UAE Microneedles for Trans & Intradermal Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Company Summary
7.1.2 Becton Dickinson Business Overview
7.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 Becton Dickinson Key News & Latest Developments
7.2 Nanopass Technologies
7.2.1 Nanopass Technologies Company Summary
7.2.2 Nanopass Technologies Business Overview
7.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Nanopass Technologies Key News & Latest Developments
7.3 Radius Health
7.3.1 Radius Health Company Summary
7.3.2 Radius Health Business Overview
7.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Radius Health Key News & Latest Developments
7.4 Clearside Biomedical
7.4.1 Clearside Biomedical Company Summary
7.4.2 Clearside Biomedical Business Overview
7.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Clearside Biomedical Key News & Latest Developments
7.5 Dr. Prausnitz Group
7.5.1 Dr. Prausnitz Group Company Summary
7.5.2 Dr. Prausnitz Group Business Overview
7.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Dr. Prausnitz Group Key News & Latest Developments
7.6 Zosano Pharma
7.6.1 Zosano Pharma Company Summary
7.6.2 Zosano Pharma Business Overview
7.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Zosano Pharma Key News & Latest Developments
7.7 Corium International
7.7.1 Corium International Company Summary
7.7.2 Corium International Business Overview
7.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Corium International Key News & Latest Developments
7.8 Circassia
7.8.1 Circassia Company Summary
7.8.2 Circassia Business Overview
7.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 Circassia Key News & Latest Developments
7.9 Valeritas, Inc.
7.9.1 Valeritas, Inc. Company Summary
7.9.2 Valeritas, Inc. Business Overview
7.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Valeritas, Inc. Key News & Latest Developments
7.10 BD Medical
7.10.1 BD Medical Company Summary
7.10.2 BD Medical Business Overview
7.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 BD Medical Key News & Latest Developments
8 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity, Analysis
8.1 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity, 2018-2029
8.2 Microneedles for Trans & Intradermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Microneedles for Trans & Intradermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Microneedles for Trans & Intradermal Drug Delivery Supply Chain Analysis
10.1 Microneedles for Trans & Intradermal Drug Delivery Industry Value Chain
10.2 Microneedles for Trans & Intradermal Drug Delivery Upstream Market
10.3 Microneedles for Trans & Intradermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Microneedles for Trans & Intradermal Drug Delivery in Global Market
Table 2. Top Microneedles for Trans & Intradermal Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Companies, 2018-2023
Table 5. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Companies, (K Units), 2018-2023
Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
Table 9. List of Global Tier 1 Microneedles for Trans & Intradermal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2018-2023
Table 15. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2024-2029
Table 16. By Application – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2018-2023
Table 20. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2024-2029
Table 21. By Region – Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2018-2023
Table 25. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2024-2029
Table 26. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2018-2023
Table 29. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2024-2029
Table 30. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2018-2023
Table 33. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2024-2029
Table 34. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2018-2023
Table 37. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2024-2029
Table 38. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2018-2023
Table 41. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2024-2029
Table 46. Becton Dickinson Company Summary
Table 47. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 48. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Becton Dickinson Key News & Latest Developments
Table 50. Nanopass Technologies Company Summary
Table 51. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 52. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Nanopass Technologies Key News & Latest Developments
Table 54. Radius Health Company Summary
Table 55. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 56. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Radius Health Key News & Latest Developments
Table 58. Clearside Biomedical Company Summary
Table 59. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 60. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Clearside Biomedical Key News & Latest Developments
Table 62. Dr. Prausnitz Group Company Summary
Table 63. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 64. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Dr. Prausnitz Group Key News & Latest Developments
Table 66. Zosano Pharma Company Summary
Table 67. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 68. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Zosano Pharma Key News & Latest Developments
Table 70. Corium International Company Summary
Table 71. Corium International Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 72. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Corium International Key News & Latest Developments
Table 74. Circassia Company Summary
Table 75. Circassia Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 76. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Circassia Key News & Latest Developments
Table 78. Valeritas, Inc. Company Summary
Table 79. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 80. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Valeritas, Inc. Key News & Latest Developments
Table 82. BD Medical Company Summary
Table 83. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 84. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. BD Medical Key News & Latest Developments
Table 86. Microneedles for Trans & Intradermal Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Microneedles for Trans & Intradermal Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Microneedles for Trans & Intradermal Drug Delivery Production by Region, 2018-2023 (K Units)
Table 89. Global Microneedles for Trans & Intradermal Drug Delivery Production by Region, 2024-2029 (K Units)
Table 90. Microneedles for Trans & Intradermal Drug Delivery Market Opportunities & Trends in Global Market
Table 91. Microneedles for Trans & Intradermal Drug Delivery Market Drivers in Global Market
Table 92. Microneedles for Trans & Intradermal Drug Delivery Market Restraints in Global Market
Table 93. Microneedles for Trans & Intradermal Drug Delivery Raw Materials
Table 94. Microneedles for Trans & Intradermal Drug Delivery Raw Materials Suppliers in Global Market
Table 95. Typical Microneedles for Trans & Intradermal Drug Delivery Downstream
Table 96. Microneedles for Trans & Intradermal Drug Delivery Downstream Clients in Global Market
Table 97. Microneedles for Trans & Intradermal Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Microneedles for Trans & Intradermal Drug Delivery Segment by Type in 2022
Figure 2. Microneedles for Trans & Intradermal Drug Delivery Segment by Application in 2022
Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Microneedles for Trans & Intradermal Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. Microneedles for Trans & Intradermal Drug Delivery Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2022
Figure 9. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 11. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 12. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 16. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 20. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 21. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 22. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 23. US Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 28. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. France Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 37. China Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. India Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 43. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 44. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2018-2029
Figure 48. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 52. Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Microneedles for Trans & Intradermal Drug Delivery by Region, 2022 VS 2029
Figure 54. Microneedles for Trans & Intradermal Drug Delivery Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経皮・皮内薬物送達用マイクロニードルの世界市場見通し2023年-2029年(Microneedles for Trans & Intradermal Drug Delivery Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経皮・皮内薬物送達用マイクロニードルの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp